Background. Severe malarial anemia (SMA) resulting from Plasmodium falciparum infection is one of the leading causes of childhood mortality in sub-Saharan Africa. The innate immune mediator macrophage migration inhibitory factor (MIF) plays a critical role in the pathogenesis of SMA.
comes of severe malaria. Because macrophage migration inhibitory factor (MIF) is a central regulator of innate immune responses to bacterial and parasitic infections [12] [13] [14] [15] [16] [17] , investigations in our laboratory have focused on the role played by MIF in malarial pathogenesis. Although studies in murine models of malaria suggest that increased MIF production causes suppression of erythropoiesis and development of SMA [18, 19] , we have recently shown that circulating MIF concentrations progressively decline with increasing anemia severity in Kenyan children with falciparum malaria [20] . These results are consistent with our previous findings in Gabon [21] showing lower MIF levels in children with acute malaria relative to levels in healthy control children and with recent data from experimental human malaria [22] demonstrating that peripheral blood MIF production significantly decreased during the course of P. falciparum infection.
Of potential importance for influencing patterns of MIF expression and disease severity in children with malaria is genetic variation in the MIF promoter. A tetranucleotide short tandem repeat polymorphism (STRP), MIF Ϫ794CATT [5] [6] [7] [8] , and a singlenucleotide polymorphism (SNP), MIF Ϫ173G/C, functionally influence susceptibility and severity to inflammatory diseases, including arthritis, atopy, lung disease, and scleroderma [23] [24] [25] [26] [27] [28] [29] . In general, longer CATT repeats (15) at Ϫ794 and the Ϫ173C allele are associated with elevated MIF production and increased susceptibility to inflammatory diseases [23] [24] [25] [26] [27] 30] . However, some investigations in chronic inflammatory diseases have observed an opposite pattern of MIF production and disease susceptibility [31, 32] . A previous study in Zambian children revealed that carriers of 15 CATT repeat alleles at Ϫ794 had a higher risk of developing HDP relative to those with the 5-repeat allele [33] . In addition, our recent investigation in a large cohort of Kenyan children demonstrated that a CC genotype at Ϫ173 was associated with increased susceptibility to HDP [9] . Although several studies have demonstrated linkage disequilibrium between polymorphisms at MIF Ϫ794 and Ϫ173, with haplotypes of the 2 loci being stronger predictors of disease risk than either one alone [23, 24, 26, 34] , the role played by MIF promoter haplotypes in conditioning susceptibility to SMA has not been reported.
To comprehensively investigate the relationship between MIF promoter polymorphisms and the pathogenesis of SMA, we examined the MIF Ϫ794 STRP in the cohort of children in whom we previously analyzed the MIF Ϫ173 SNP [9] and constructed haplotypes for the 2 loci. Data presented here show a significant relationship between malarial disease severity and the Ϫ794 STRP, independent of the Ϫ173 SNP. In addition, results presented here demonstrate, for the first time, an association between MIF Ϫ794 and Ϫ173 haplotypes, susceptibility to SMA, and peripheral blood MIF production that appears to be independent of the effect of MIF polymorphisms on HDP.
METHODS
Study site. This study was conducted as part of our ongoing investigations at the Siaya District Hospital in western Kenya examining the genetic and immunological basis of pediatric SMA [35] . This community has holoendemic P. falciparum transmission where residents receive up to 300 infective mosquito bites per annum, and the prevalence of P. falciparum infection is 83% in children 1-4 years of age, with SMA and HDP being the primary clinical manifestations of severe malaria [35, 36] .
Study participants. Children !3 years of age ( ) n p 643 presenting at the hospital with acute malaria (or for routine immunizations) were recruited into the study. All study participants were from the Luo ethnic group [35] , thus providing a homogenous population for the genetic investigations. After written informed consent was obtained from the parents or guardians, capillary blood was collected from study participants for determination of parasitemia and initial hemoglobin levels. Children with detectable P. falciparum parasitemia (acute malaria;
) were categorized into 2 groups according to n p 519 their anemia status: non-SMA (hemoglobin level у6.0 g/dL; ) and SMA (hemoglobin level !6.0 g/dL; ). The n p 309 n p 210 definition of SMA was based on the distribution of anemia determined by 114,000 longitudinal hemoglobin measurements in age-and sex-matched children from the same geographic location [37] . In addition, HDP (у10,000 parasites/mL) was based on the distribution of parasitemia in the population determined in previous studies [35, 38] . Control children without parasitemia (the aparasitemia group; ) were those with n p 124 P. falciparum-negative blood smears who had been free of fever or other symptoms of malaria during the preceding 2 weeks before enrollment. Exclusion criteria included coinfection with other Plasmodium species, prior hospitalization and/or transfusion for any cause, and cerebral malaria.
The present study was approved by the Ethics Committee of the Kenya Medical Research Institute, the University of Pittsburgh Institutional Review Board, and the University of New Mexico Institutional Review Board.
Sample collection and laboratory evaluation. Before administration of antimalarial therapy and supportive care, venous blood was collected into tubes containing the anticoagulant ethylenediaminetetraacetic acid. The blood sample was used for a complete blood count and hemoglobin determination (Coulter A c T diff2; Beckman Coulter), plasma preparation, and human immunodeficiency virus type 1 (HIV-1) testing. Peripheral blood smears were stained with Giemsa reagents and examined for plasmodial parasites under oil immersion. The number of parasites per 300 white blood cells NOTE. DNA samples obtained from study participants were genotyped for the short tandem repeat polymorphism (CATT [5] [6] [7] [8] ) at Ϫ794 of the MIF promoter by amplifying the target region with flanking primers and resolving the products by capillary electrophoresis. Genotypic and allelic frequencies are expressed as the percentage of each clinical group.
was determined, and parasite density (parasites per microliter of blood) was calculated using the total white blood cell count obtained from the automated hematology analyzer. Sickle-cell status was determined by alkaline cellulose acetate electrophoresis on Titan III plates (Helena BioSciences), in accordance with the manufacturers' recommendations. HIV-1 status was determined using 2 serological methods followed by proviral DNA polymerase chain reaction, as described elsewhere [39] . All parents or guardians of the study participants received preand posttest HIV/AIDS counseling. At the time of enrollment, none of the children had begun receiving antiretroviral therapy.
Genetic analyses. Blood spots were collected on FTA Classic cards (Whatman), and DNA was extracted using the Gentra system (Gentra System). Methods that have been described elsewhere were used to genotype samples for the MIF-794 STRP [27] and the MIF-173 SNP [9] .
Determination of MIF concentrations. MIF concentrations in plasma samples were determined using an enzyme- linked immunosorbent assay with a matched anti-MIF antibody pair (R&D Systems), in accordance with the manufacturer's recommendations. The limit of detection was 131.25 pg/mL.
Data analyses. Comparison of variables across the 3 clinical groups (aparasitemia, non-SMA, and SMA) were conducted using the Kruskal-Wallis test; where significant differences were obtained, the Mann-Whitney U test was used for pairwise comparisons. Circulating MIF levels between groups were compared using the Mann-Whitney U test. The association between CATT repeat length and the severity of malarial anemia was determined using the Cochran-Armitage trend test for proportions [40] , as implemented in the coin package [41] , available for the R statistical program (version 2.9) [42] , whereas the association between repeat length and MIF concentration was determined using the Cochran-Armitage trend test for counts [43] . MIF promoter haplotypes were constructed from the Ϫ173G/C and Ϫ794CATT n genotype data using the HPlus software program (version 3.1; Fred Hutchinson Cancer Research Center). Agreement with Hardy-Weinberg equilibrium was tested using the procedure of Guo and Thompson [44] , as implemented in the software program Arlequin (version 3.11) [45] . This program was also used to measure linkage disequilibrium between the Ϫ173 and Ϫ794 loci by the likelihood ratio test. For analysis of association between disease and genetic variants, 3 primary outcomes were defined: presence of parasitemia, HDP, and SMA. Multivariate logistic regression analyses were conducted for each of these outcomes using genotype or haplotype, age, sex, sickle-cell trait, and HIV-1 status as independent predictors. HIV-1 status was entered as a dichotomous variable for exposed or nonexposed, whereby children with a positive polymerase chain reaction test result and/or a positive serological test result were considered to be exposed.
RESULTS
Characteristics of study participants. Children (age range, 3-32 months) were categorized into 3 clinical groups: aparasitemia ( ), non-SMA ( ), and SMA ( ). n p 124 n p 309 n p 210 Differences in sex distribution across the groups were not statistically significant ( ) (table 1) . However, age differed P p .217 across the groups ( ), with children in the non-SMA P p .001 group being older than those in the other 2 groups (P ! .001 for both comparisons). Axillary temperature differed across the groups (
) and was elevated in the acute malaria groups P p .003 relative to the aparasitemia group ( for both compar-P ! .001 isons). Hemoglobin level, which was used in the categorization criteria, differed across the groups, as expected (
). How-P ! .001 ever, parasitemia, as well as the prevalence of HDP, did not significantly differ between the non-SMA and SMA groups ( and , respectively). P p .138 P p .307 Distribution of MIF 5794 genotypes and alleles. To investigate the association between variation in the MIF Ϫ794CATT repeat and malarial pathogenesis, frequency distributions of the MIF Ϫ794 genotypes and alleles were determined in the 3 clinical groups (aparasitemia, non-SMA, and SMA). The 5,6 genotype was the most frequent in all 3 groups (23%-34%), whereas the 5,8 genotype, the 7,8 genotype, and the 8,8 genotype were the rarest (overall frequencies, !1%) (table 2). The most prevalent Ϫ794 allele in the clinical groups was the 5-repeat allele (42%-48%), whereas the 8-repeat allele showed the lowest frequency (1%-3%) (table 2). Frequencies of the 5-and 6-repeat alleles decreased across the groups with increasing severity of malarial anemia, whereas the 7-and 8-repeat alleles were increased ( NOTE. MIF promoter haplotypes were constructed from the Ϫ794 short tandem repeat polymorphism data shown in table 2, and Ϫ173 single-nucleotide polymorphism genotypes were determined as described elsewhere [9] using HPlus software. Complete data for both loci were available for 448 children, resulting in a total of 896 haplotypes. The frequencies for individual haplotypes are expressed as the percentage of total haplotypes.
creasing frequencies of longer repeat lengths (and decreasing frequencies of shorter repeats) and increasing malarial anemia severity (aparasitemia less than non-SMA less than SMA), suggesting an association between MIF Ϫ794 alleles and susceptibility to SMA.
Association between MIF 5794 genotypes and disease. Based on the frequency distribution of the Ϫ794 repeat in our cohort (table 2) and previous studies demonstrating that an increasing number of CATT repeats are associated with enhanced susceptibility to inflammatory diseases [26, 27, 33] Relationship between MIF 5794CATT repeat length and circulating MIF levels. The relationship between CATT repeat length and MIF production was investigated by examining circulating MIF levels in carriers of the different alleles. In contrast to previously reported patterns [24, 27] , the present analyses showed a progressive decrease in circulating MIF concentrations with carriage of longer CATT repeats ( across P p .039 groups) (table 4). Additional analyses using the Cochran-Armitage trend test for counts [43] showed a strong association between lower MIF concentrations and longer CATT repeats ( ), suggesting that carriers of the disease-associated al-P ! .001 leles have decreased peripheral blood MIF production.
MIF promoter haplotypes. To examine the effect of interactions between the Ϫ794 and Ϫ173 loci and susceptibility to severe malaria, haplotypes of the 2 polymorphic sites were constructed. In contrast to previous studies from other regions in which the 5C haplotype (ie, Ϫ794CATT 5 /Ϫ173C) was rare [26, 31, 34] , the most common haplotype in the cohort was 5C (31%), whereas the 8G haplotype had the lowest frequency (!1%) (table 5). The distribution of haplotypes showed significant departure from Hardy-Weinberg equilibrium (P ! ). In addition, there was significant evidence of linkage .001 disequilibrium between the Ϫ794 and Ϫ173 polymorphic sites (likelihood ratio x 2 , 42.4; ). Of particular interest, the P ! .001 proportion of 5G to 5C and of 6G to 6C differed ∼2-fold, whereas there was a disproportionately higher prevalence of 7C and 8C relative to 7G and 8G (ie, 9-and 4-fold difference, respectively) (table 5), suggesting potential interactions between the 2 polymorphic sites.
Association between MIF promoter haplotypes and disease. To determine whether MIF haplotypes were associated with susceptibility to malaria, relationships between haplotypes and primary disease outcome variables were analyzed. These analyses revealed that MIF haplotypes were significantly associated with SMA ( ) but not the presence of parasitemia P p .020 ( ) or susceptibility to HDP ( ). The associa-P p .220 P p .830 tion between MIF haplotypes and SMA was, therefore, further examined by comparing the frequencies of individual haplotypes in the non-SMA versus SMA groups to identify potential severe disease-associated haplotypes ( figure 1A) . The frequency of the 6G haplotype was substantially underrepresented in children with SMA, whereas the 7C and 8C haplotypes appeared to be overrepresented in the SMA group ( for all com-P р .1 parisons) (figure 1), suggesting possible associations with susceptibility to SMA. Additional analyses using the logistic regression model demonstrated that children with the 6G haplotype were 37% less susceptible to SMA than children without this haplotype ( ) (table 6) . Conversely, children P p .050 with the 7C haplotype had a 60% increased risk of SMA relative to those without 7C, although this difference did not reach statistical significance ( ) (table 6 ). When carriers of P p .064 the 7C or 8C haplotypes were combined, however, these children had a 71% increased risk of SMA relative to children without 7C and 8C ( ) (table 6 ). Because children with P p .031 CC at MIF Ϫ173 have significantly increased susceptibility to HDP [9] , it was of interest to determine whether the risk of SMA was further exacerbated in the subset of individuals with Figure 1 . A, Association between MIF promoter haplotypes and susceptibility to severe malarial anemia (SMA). Haplotypes were constructed from the MIF Ϫ794CATT 5-8 and Ϫ173G/C genotype data using HPlus software, and the frequencies of each haplotype in children with SMA or malaria without severe anemia (non-SMA) are expressed as percentages. Differences in haplotype frequencies between the 2 groups were compared using the Fisher exact test. # for the comparison with P ! .10 the non-SMA group. B and C, Functional relationship between SMAassociated haplotypes and circulating macrophage migration inhibitory factor (MIF) levels. Plasma levels of MIF were determined in control children with acute malaria and in children without parasitemia (the aparasitemia group) by enzyme-linked immunosorbent assay. In panel B, MIF levels in the control (for non-6G, ; for 6G, ) and malaria n p 33 n p 23 (for non-6G, ; for 6G, ) groups are presented according n p 137 n p 102 to carriage of the MIF Ϫ794/Ϫ173 haplotype 6G. In panel C, MIF levels in the control (for non-7C and non-8C, ; for 7C and 8C, ) n p 45 n p 11 and malaria (for non-7C and non-8C, ; for 7C and 8C, ) n p 165 n p 74 groups are presented according to carriage of the MIF Ϫ794/Ϫ173 haplotypes 7C or 8C. Boxes represent interquartile ranges, lines through the boxes represents medians, whiskers represent the tenth and 90th percentiles, and symbols represent outliers. * (statistically significant P ! .05 difference by the Mann-Whitney U test).
the Ϫ173 CC genotype who carried a 7C or 8C haplotype. These analyses revealed that the risk of SMA was nearly 2.5-fold higher in this subset of children (odds ratio, 2.46 [95% confidence interval, 1.37-4.43];
), demonstrating an P p .003 even further increase over the risk observed in the 7C/8C haplotype group as a whole. Thus, genetic variation within the MIF promoter at the Ϫ173 and Ϫ794 polymorphisms can both confer protection against SMA or condition increased susceptibility to SMA in children with P. falciparum.
Functional relationship between MIF haplotypes and MIF production. Because P. falciparum infection causes dysregulation in MIF production [18] [19] [20] [21] , the relationship between disease-associated haplotypes and circulating MIF levels was examined separately in children without parasitemia and children with acute malaria. Circulating levels of MIF were not significantly different between children with and those without the 6G haplotype in either the aparasitemia or acute malaria categories ( and , respectively) (figure 1B). P p .739 P p .796 However, possession of the 7C or 8C haplotype was associated with lower circulating MIF levels in both children in the aparasitemia group ( ) and children with acute malaria P p .103 ( ) ( figure 1C ) relative to non-7C/8C children. These P p .034 data suggest that MIF promoter haplotypes associated with susceptibility to SMA are functionally related to peripheral blood MIF production.
DISCUSSION
We recently demonstrated that variation at MIF Ϫ173 was associated with susceptibility to HDP, but not SMA, in the cohort of Kenyan children examined here [9] . In the present study, a more comprehensive examination of the role played by genetic variation in the MIF promoter in conditioning susceptibility to severe childhood malaria was conducted by analyzing the MIF Ϫ794 STRP and haplotypes of MIF Ϫ794 and Ϫ173. Consistent with previous observations in Zambian children [33] , the 5-repeat allele was the most prevalent MIF Ϫ794 allele in the Kenyan cohort. This distribution of Ϫ794 alleles differs from patterns reported in white [27] and Northeast Asian [34] populations, where the 6-repeat allele was predominant. Thus, there appears to be significant geographic variation in the dis- NOTE. Association between MIF promoter haplotypes and susceptibility to SMA was determined using multivariate logistic regression, controlling for age, sex, human immunodeficiency virus type 1 status, and sickle-cell trait. Odds ratios with 95% confidence intervals (CIs) and P values represent the risk of SMA in carriers of the indicated haplotypes compared with that in noncarriers.
tribution of the MIF Ϫ794 STRP, as previously documented for the MIF Ϫ173 SNP [9, 28, 33] .
In areas of holoendemic transmission, such as our present study site in western Kenya, nearly all children experience multiple clinical episodes of malaria during the first 5 years of life [4] . Although a majority of these infected children present with only mild forms of malaria, others experience severe life-threatening complications that predominantly manifest as SMA [35] . Therefore, identifying gene variants associated with susceptibility to severe disease is best accomplished by comparing the genetic backgrounds of P. falciparum-infected children who develop SMA with those of children who do not develop SMA. The effect of MIF promoter polymorphisms on susceptibility to SMA was investigated by examining MIF variants in 3 clinically distinct groups: healthy control children without parasitemia, P. falciparum-infected children without SMA, and children with SMA. Trend analyses showed a significant pattern of increased malarial anemia severity in carriers of longer CATT (7 and 8) repeat alleles, suggesting a potential relationship with susceptibility to SMA.
Additional multivariate logistic regression analyses controlled for the confounding effects of age, sex, sickle-cell trait, and HIV-1 status. Although many factors, including nutritional indices, coinfections with other pathogens, and parents' socioeconomic status, could influence disease outcomes, only those factors that were found to significantly affect the pathogenesis of SMA in this population [35, 38, 39] were included in the multivariate models. In addition, since data presented here and in our previous studies [9, 20, 35, 46] demonstrate that SMA is not significantly associated with concomitant parasitemia, HDP and SMA were examined as separate outcome variables. These analyses identified a relationship between the presence of longer repeat alleles and susceptibility to SMA, but not HDP. Interestingly, this association was statistically significant for heterozygous longer-repeat carriers (XY) but not homozygous individuals (YY), perhaps because of the limited sample size of the homozygous group. Children in the XY group had a significantly increased likelihood of having parasitemia (any density) compared with children in the XX group, suggesting that carriage of a shorter number of repeats may protect against acquisition of P. falciparum infection. However, because the parasitemia status of children in areas of high transmission intensity is dynamic, longitudinal studies are required to definitively show an association between MIF genetic variants and susceptibility to infection over extended periods of exposure.
Although the MIF Ϫ794 STRP and Ϫ173 SNP are independently associated with various diseases [28] , haplotypes of the 2 polymorphic sites are more strongly associated with functional gene expression and susceptibility to inflammatory disease [24, 26, 34] . Therefore, MIF promoter haplotypes were constructed, and the association between the various haplotypes and severity of malarial anemia was investigated. Because the distribution of the 7C and 8C haplotypes showed similar patterns in the SMA and non-SMA groups, these 2 haplotypes were combined for increased statistical power. Despite the lack of an independent association between the Ϫ173 SNP and SMA, haplotypic analyses revealed that the 6G haplotype was protective against SMA, whereas the 7C and 8C haplotypes were associated with increased susceptibility to SMA. Although the 7C haplotype is associated with several inflammatory diseases, including scleroderma [47] , atopy [34] , and inflammatory arthritis [26] , to our knowledge this is the first report of an association between the 6G haplotype and protection from any disease. Moreover, the role played by the 8C haplotype has not been previously examined because of the extremely low frequency of this haplotype in most populations [28, 31] . Additional analyses revealed that susceptibility to SMA was further increased in children who had the SMA-susceptible haplotype (ie, 7C or 8C) in combination with the HDP-susceptible CC genotype at Ϫ173 [9] , suggesting that the impact of these disease-susceptibility traits may be synergistic.
The mechanism by which MIF promoter variants influence susceptibility to SMA was further investigated by examining peripheral blood MIF production in children with and those without parasitemia separately, allowing us to distinguish the potential effect of genetic variation on basal MIF production from changes that result from host-parasite interactions. Overall, there was a progressive decline in MIF levels among children with increasing length of CATT repeats. Furthermore, although the 6G haplotype showed no significant relationship with MIF production, carriage of the 7C or 8C haplotype was associated with decreased MIF production during acute disease. These observations contrast with those of previous in vitro studies in various cell types demonstrating that increased MIF production is associated with an increasing number of CATT repeats [24, 27] and that MIF production is increased in individuals with the 7C haplotype relative to those with non-7C haplotypes [47] . However, the results presented here are consistent with the findings of previous investigations demonstrating that MIF ex-pression is significantly suppressed in 7C promoter constructs compared with 5G and 6G constructs [34] , illustrating the complexity of MIF transcriptional regulation. The data presented here showing that the 7C and 8C haplotypes are associated with increased susceptibility to SMA and reduced MIF expression are in agreement with our previous investigations demonstrating that MIF production is decreased in Kenyan children with SMA [20] . These data also support our recent study illustrating that the MIF production in response to malaria is influenced by variation in the MIF promoter [9] , suggesting that adequate MIF production may play an important role in mediating protective immune responses to P. falciparum infection.
